Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors: A Multicenter Phase 2 Trial...

Emons, Günter; Gorchev, Grigor; Harter, Philipp; More

International Journal of Gynecological Cancer . 24(2):260-265, February 2014.